UK – NICE collaboration creates new route for medicines approval

A collaboration between the UK's National Institute for Health and Care Excellence (NICE), drug regulators, the NHS and equivalent organisation in Scotland has opened a new route for medicine approval in the UK.

The new Innovative Licensing and Access Pathway (ILAP) aims to ease the process between clinical trials and patient access to new medications through closer collaboration and planning between the respective agencies.

The pathway is focused on ensuring that NHS patients can gain access to innovative new medicines in a simpler and faster way.

“NICE has a central role in ensuring flexible and swift access to innovative medicines for patients in England and supporting the life sciences sector to launch their products here,” said Gillian Leng, chief executive of NICE…